BF Biosciences Statistics

Total Valuation

BF Biosciences has a market cap or net worth of PKR 11.58 billion. The enterprise value is 11.32 billion.

Market Cap	11.58B
Enterprise Value	11.32B

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

BF Biosciences has 88.33 million shares outstanding. The number of shares has increased by 28.87% in one year.

Current Share Class	88.33M
Shares Outstanding	88.33M
Shares Change (YoY)	+28.87%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.13%
Float	25.00M

Valuation Ratios

The trailing PE ratio is 19.34.

PE Ratio	19.34
Forward PE	n/a
PS Ratio	1.41
PB Ratio	2.31
P/TBV Ratio	2.31
P/FCF Ratio	34.76
P/OCF Ratio	16.22
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.97, with an EV/FCF ratio of 33.97.

EV / Earnings	18.91
EV / Sales	1.38
EV / EBITDA	8.97
EV / EBIT	11.53
EV / FCF	33.97

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.32.

Current Ratio	1.71
Quick Ratio	0.77
Debt / Equity	0.32
Debt / EBITDA	1.29
Debt / FCF	4.88
Interest Coverage	12.74

Financial Efficiency

Return on equity (ROE) is 12.71% and return on invested capital (ROIC) is 11.96%.

Return on Equity (ROE)	12.71%
Return on Assets (ROA)	6.66%
Return on Invested Capital (ROIC)	11.96%
Return on Capital Employed (ROCE)	14.48%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	15.37M
Profits Per Employee	1.12M
Employee Count	535
Asset Turnover	0.89
Inventory Turnover	2.35

Taxes

In the past 12 months, BF Biosciences has paid 410.92 million in taxes.

Income Tax	410.92M
Effective Tax Rate	40.70%

Stock Price Statistics

The stock price has decreased by -23.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.79%
50-Day Moving Average	155.31
200-Day Moving Average	161.01
Relative Strength Index (RSI)	30.58
Average Volume (20 Days)	417,841

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BF Biosciences had revenue of PKR 8.22 billion and earned 598.64 million in profits. Earnings per share was 6.78.

Revenue	8.22B
Gross Profit	3.31B
Operating Income	982.11M
Pretax Income	1.01B
Net Income	598.64M
EBITDA	1.26B
EBIT	982.11M
Earnings Per Share (EPS)	6.78

Full Income Statement

Balance Sheet

The company has 1.89 billion in cash and 1.63 billion in debt, giving a net cash position of 261.34 million or 2.96 per share.

Cash & Cash Equivalents	1.89B
Total Debt	1.63B
Net Cash	261.34M
Net Cash Per Share	2.96
Equity (Book Value)	5.01B
Book Value Per Share	56.71
Working Capital	2.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 714.17 million and capital expenditures -380.93 million, giving a free cash flow of 333.25 million.

Operating Cash Flow	714.17M
Capital Expenditures	-380.93M
Free Cash Flow	333.25M
FCF Per Share	3.77

Full Cash Flow Statement

Margins

Gross margin is 40.29%, with operating and profit margins of 11.94% and 7.28%.

Gross Margin	40.29%
Operating Margin	11.94%
Pretax Margin	12.28%
Profit Margin	7.28%
EBITDA Margin	15.35%
EBIT Margin	11.94%
FCF Margin	4.05%

Dividends & Yields

BF Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.87%
Shareholder Yield	-28.87%
Earnings Yield	5.17%
FCF Yield	2.88%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BF Biosciences has an Altman Z-Score of 3.63 and a Piotroski F-Score of 5.

Altman Z-Score	3.63
Piotroski F-Score	5